Medicine
Betamethasone valerate 1 mg/mL lotion
Betamethasone valerate 1 mg/mL lotion is a generic prescription medicine for topical use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 15° - 30°C (59° - 86°F). Store away from heat and…
Key facts
- Active ingredient (INN)
- Betamethasone valerate
- Brand
- Sold under the generic name
- Strength
- 1 mg/mL
- Dosage form
- Lotion
- Route
- Topical
- Packs
- 60 mL
- Manufacturer
- E. Fougera
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 15° - 30°C (59° - 86°F). Store away from heat and protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 August 1983
- Identifiers
- RxCUI 197407, 197408, 197409DailyMed set ID 0b386ccc-a2d4-4d18-a2d7-e46ff894c674NDC 0168-0041Application NDA018866
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 mL in 1 bottle | 0168-0041-60 | E. Fougera | 31 August 1983 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 September 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Betamethasone valerate
Clinical summary
Betamethasone valerate is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream, foam and ointment for topical use. MedsAcross supplies Betamethasone valerate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Betamethasone valerateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Betamethasone Valerate prescribing information (Cosette Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Betamethasone valerate 1 mg/mL lotion for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.